$TMDX SEC Filings

Filed On	Filing
29 Sep 2026	Form 3: Araujo Fernando N., See Remarks No securities owned
14 Sep 2026	Form 4: Weill David, Director Bought 1,336 shares ($109K)
10 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure Andover, Mass. – September 10, 2026 – TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), the global leader in portable warm perfusion for donor organs for transplantation, today announced the appointment of Fernando Araujo as Chief ...
17 Aug 2026	Form 4: Tobin James R, Director Gave 18,000 shares as a gift
04 Aug 2026	10-Q
04 Aug 2026	8-K: Results of Operations and Financial Condition
14 Jul 2026	Form 4: Corcoran Nicholas, See remarks Received 11,727 shares as a grant or award · Granted 17,784 Stock Option (Right to Buy)
14 Jul 2026	Form 4: Hernandez Gerardo, Chief Financial Officer Received 17,246 shares as a grant or award · Granted 26,153 Stock Option (Right to Buy)
14 Jul 2026	Form 4: Hassanein Waleed H, Director Received 49,669 shares as a grant or award · Granted 112,984 Stock Option (Right to Buy)
17 Jun 2026	Form 4: Gunderson Thomas J., Director Received 19,285 shares by exercise or conversion ($42.6K) · Sold 9,624 shares ($722K)
15 Jun 2026	144
29 May 2026	SD
22 May 2026	Form 4: Lovell Stephanie, Director Received 2,922 shares as a grant or award
22 May 2026	Form 4: Weill David, Director Received 2,922 shares as a grant or award
22 May 2026	Form 4: Raines Merilee, Director Received 2,922 shares as a grant or award
22 May 2026	Form 4: Gunderson Thomas J., Director Received 2,922 shares as a grant or award
22 May 2026	Form 4: Basile Edward M, Director Received 2,922 shares as a grant or award
22 May 2026	Form 4: Tobin James R, Director Received 2,922 shares as a grant or award
22 May 2026	Form 4: Kania Edwin, Director Received 2,922 shares as a grant or award
21 May 2026	Form 4: Forsyth Matthew S., See Remarks Received 15,409 shares as a grant or award · Granted 23,171 Stock Option (Right to Buy)

Comments